Insider trades

Scilex Holding, 10% Owner of Semnur Pharmaceuticals SMNR, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $57.9M. The latest trade was on 06/15.

Scilex Holding

10% Owner
First filing
25/09/25
Trades
18 trades
Buys / sales
0 / 15
12-month net buying
−$57.9M
Last trade
06/15

Trading activity

Transactions

Trade type
DVLT
Open-market sale01/12–01/1401/1415,965,541 sh3 trades$0.83avg.$13,236,436.49−6.9%
DVLT
Open-market sale01/06–01/0801/0814,713,490 sh3 trades$1.24avg.$18,188,172.23−6.0%
DVLT
Open-market saleAmendment25/12/26–25/12/3025/12/3120,657,300 sh3 trades$0.62avg.$12,806,953.44−7.8%
SCLX
Open-market sale25/12/26–25/12/3025/12/3020,657,300 sh3 trades$0.62avg.$12,806,953.44−7.8%
Open-market sale25/11/2825/11/28422,299 sh$2.06$869,935.94−0.2%
SMNR
Open-market sale25/09/2325/09/2512,500,000 sh2 trades$16.00avg.$200,000,000No record